Life Science News
Latest updates from the biotech and pharma world
Chengdu Chipscreen Pharmaceutical describes new Mat2A inhibitors
New SIK inhibitors disclosed in Insilico Medicine patent
Samsung Life Public Welfare Foundation discovers new TLR signaling inhibitors
Otsuka’s IgAN therapy gets a thumbs-up from the FDA
Financings for Nov. 25, 2025
In the clinic for Nov. 25, 2025
Other news to note for Nov. 25, 2025
Regulatory actions for Nov. 25, 2025
Protara sees Chugai blue sky in LMs as phase II data strong
Appointments and advancements for Nov. 24, 2025
#Galvanize Therapeutics#med-tech industry#Labcorp#including#BioCardia
In the clinic for Nov. 25, 2025
#Jyong Biotech#Clinical updates#including trial#trial initiations#enrollment status
Financings for Nov. 25, 2025
#Cassidy Bio#Asia-Pacific raising#raising money#private financings#Nov.
Other news to note for Nov. 25, 2025
#Mankind Pharma#Biopharma happenings#preclinical data#Asia-Pacific including#including deals
Regulatory actions for Nov. 25, 2025
#Obi Pharma#including drug#clinical trial#Regulatory snapshots#drug submissions
Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs
#phase III#drugs Detailed#Detailed data#III study#scientific congress
Novo’s semaglutide fails in phase III Alzheimer’s trials
#phase III#III Alzheimer#Novo Nordisk#treat Alzheimer#receptor agonist
Data back spinal injury bid from Nervgen in phase Ib/IIa
#Pharma Corp#Nervgen Pharma#IIa Nervgen#Data back#Nervgen
Today's news in brief
#BioWorld MedTech#Nov.#Today#BioWorld#MedTech
Regulatory actions for Nov. 24, 2025
#Transmural Systems#including global#clinical trial#Regulatory snapshots#global submissions